Blood IL-1α and IL-6 predict specific breast cancer-induced increases in hippocampal pro-inflammatory cytokines in mice

  • 0Laboratory of ImmunoPsychiatry, Neuroscience Research Australia, Randwick, New South Wales, Australia; Discipline of Psychiatry and Mental Health, Faculty of Medicine, University of New South Wales, Sydney, Australia.

|

|

Summary

This summary is machine-generated.

Neuroinflammation from cancer impacts brain function. While blood cytokines can indicate brain inflammation, they may not capture all changes, suggesting a need for broader markers to identify at-risk cancer patients.

Area Of Science

  • Neuroscience
  • Immunology
  • Oncology

Background

  • Neuroinflammation is linked to cancer-related cognitive and behavioral issues.
  • Blood cytokine levels are often used as indirect measures of brain inflammation, but results are inconsistent.
  • A clear inflammatory signature across different cancer types is yet to be established.

Purpose Of The Study

  • To investigate if a consistent blood-to-brain inflammatory signature exists across different types of breast cancer.
  • To assess cytokine and glial protein responses in specific brain regions (hippocampus, prefrontal cortex) and their correlation with serum cytokines in mice with mammary cancers.

Main Methods

  • Mice (n=40) bearing three distinct mammary cancer types were studied.
  • Cytokine levels in serum and brain tissue (hippocampus, prefrontal cortex) were measured.
  • Glial protein responses in brain regions were analyzed and correlated with serum cytokine levels.

Main Results

  • Cytokine profiles varied by cancer type in both serum and brain, but Interleukin-1 beta (IL-1β) and Interleukin-4 (IL-4) showed consistent alterations across brain regions.
  • Elevated serum IL-1α and IL-6 correlated with increased hippocampal IL-6 in some instances.
  • The hippocampus exhibited greater vulnerability to cancer-induced inflammation than the prefrontal cortex, with region-specific glial cell reactivity observed.

Conclusions

  • Blood cytokines can help identify cancer patients at risk for cognitive and psychiatric problems.
  • Relying solely on serum cytokines may lead to under-diagnosis; broader inflammatory markers are needed.
  • Brain region-specific differences in inflammatory responses highlight the hippocampus's vulnerability and the potential of specific cytokines to indicate glial cell changes.